NSE filing, NSE: INDGN. Summary written from the filing by ALFA Finder's alert engine.
Indegene Ltd: key numbers
- Share price
- ₹598.95
- Market cap
- ₹14,430 Cr
- Revenue (annual)
- ₹3,510 Cr
- Net profit (annual)
- ₹401.1 Cr
- P/E (TTM)
- 36.0×Sector 52.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 12.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indegene Ltd
All →Indegene Merger & Restructuring
Indegene Ltd disclosed that its step-down wholly owned subsidiary, Indegene Portugal Unipessoal LDA, was incorporated on 23 October 2026. The entity has nil turnover and is yet to begin operations.
Indegene Business Update
Indegene received Frost & Sullivan's 2026 Global Enabling Technology Leadership award for AI-powered pharma commercialization. The recognition highlights its domain-led AI platform and workflow transformation capabilities.
Indegene Other Announcement
Indegene Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing details share distribution across promoter and public shareholder categories.
Indegene Management Change
Indegene's Non-Executive Director Mr. Mark Dzialga resigned effective October 29, 2026, following Brighton Park Capital's sale of its entire stake. No other material board changes are disclosed.
Indegene Employee Stock Options
Indegene Limited has allotted 16,110 equity shares under its ESOP Scheme 2020. The board also approved an amendment to the company's POSH policy.
Indegene Business Update
Indegene held its 2026 Digital Summit in Philadelphia, drawing 120+ pharma leaders and 19 speakers. The event showcased the company's AI-native pharma enablement capabilities.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.